| PharmaSUG |
2026 |
Biostatistical Foundations 201: Privacy Preserving Patient Linkage Across Real World Data Sources |
|
source |
8 |
| PharmaSUG |
2026 |
Operationalizing Real World Data for External Control Arms: An End to End Framework for Rare Disease and Oncology Trials |
|
source |
7 |
| PharmaSUG |
2025 |
Unveiling Paradoxical Pathways: A Counterintuitive Compass for Strategic Decision-Making |
|
source |
14 |
| PharmaSUG |
2024 |
A Framework for Risk-Based Oversight for Fully Outsourced Clinical Studies |
AstraZeneca Rare |
source |
7 |
| PharmaSUG |
2024 |
Protocol Amendments and EDC Updates: Downstream impact on Clinical Trial Data |
Ram Gudavalli, Kumar Bhimavarapu |
source |
11 |